Citius Pharmaceuticals CTXR Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS estimate-$1.08
Next report
Aug 11, 2026 (In 4 weeks)Revenue estimate$5.5M
EPS estimate-$0.36
Versus estimates
Ask the moment Citius Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Citius Pharmaceuticals report Q1 2025 earnings?
- Citius Pharmaceuticals (CTXR) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Citius Pharmaceuticals's Q1 2025 revenue and EPS?
- Citius Pharmaceuticals reported diluted EPS of $-1.27 for Q1 2025.
- Did Citius Pharmaceuticals beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-1.08 by $0.19.
- How did Citius Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 1.6% from $-1.25.
- Where can I find Citius Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-043360) directly on SEC EDGAR. The filing index links above go to sec.gov.